Cascade of Care for HIV, Hepatitis and Sexually Transmitted Infections

A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Human Virology and Viral Diseases".

Deadline for manuscript submissions: 31 July 2025 | Viewed by 359

Special Issue Editor


E-Mail Website
Guest Editor
Hospital for Infectious Diseases, Department of Adults' Infectious Diseases, Medical University of Warsaw, Warsaw, Poland
Interests: HIV; infection; HIV immunology; HIV prevention; infectious disease epidemiology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The care cascade is a concept used to assess and improve the engagement of people living with HIV at various stages of HIV care and treatment. It helps identify gaps in the continuity of care and develop strategies to ensure that people living with HIV receive the health services and support that they need. This concept was so effective that it deserved to be transferred to other infectious diseases, especially hepatitis B virus (HBV), hepatitis C virus (HCV), and other sexually transmitted viruses.

This comprehensive approach ensures that individuals receive the screening, diagnosis, treatment, and support that they need, ultimately improving their overall health and well-being. Promoting the well-being of people living with HIV goes beyond clinical care to address their overall quality of life and holistic health.

The purpose of this Special Issue is to collect research related to HIV, viral hepatitis, and other sexually transmitted viruses, covering topics ranging from early diagnosis and effective treatment to well-being and quality of life.

Prof. Dr. Justyna Dominika Kowalska
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • HIV
  • AIDS
  • cascade
  • linkage
  • HCV
  • HBV
  • sexually transmitted infections

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Related Special Issue

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

11 pages, 827 KiB  
Article
Prevalence of Sexually Transmitted Infections Among Cisgender Women Coming to a Walk-In Center
by Gaia Catalano, Tommaso Clemente, Sara Diotallevi, Riccardo Lolatto, Benedetta Trentacapilli, Martina Ranzenigo, Elena Bruzzesi, Paola Cinque, Antonella Castagna and Silvia Nozza
Viruses 2025, 17(4), 498; https://doi.org/10.3390/v17040498 - 29 Mar 2025
Viewed by 258
Abstract
The general female population is not considered a high-risk group for screening for sexually transmitted infections (STIs). This retrospective study describes the prevalence of Human Immunodeficiency Virus (HIV), Treponema pallidum (T. pallidum), Chlamydia trachomatis (C. trachomatis), Neisseria gonorrhoeae ( [...] Read more.
The general female population is not considered a high-risk group for screening for sexually transmitted infections (STIs). This retrospective study describes the prevalence of Human Immunodeficiency Virus (HIV), Treponema pallidum (T. pallidum), Chlamydia trachomatis (C. trachomatis), Neisseria gonorrhoeae (N. gonorrhoeae), Trichomonas vaginalis (T. vaginalis), Mycoplasma spp., Ureaplasma spp., genital Herpes simplex virus (HSV), Monkeypox (mpox), Hepatitis B virus (HBV), and Hepatitis C virus (HCV) infections in asymptomatic and symptomatic cisgender women attending our walk-in STI clinic for the first time. Furthermore, it analyzes the number of individuals who returned for follow-up and were diagnosed with new STIs. Over 20 months, 189 women with a median age of 28.4 years were screened [129 (68.3%) asymptomatic and 60 (31.8%) symptomatic]. In order of prevalence, the most common STIs were: Ureaplasma spp. infections (50.3%), C. trachomatis (10.6%), N. gonorrhoeae (5.8%), Mycoplasma hominis infections (5.8%), T. pallidum (2.65%), HSV2 infections (2.65%), and mpox (0.53%). No diagnosis of HIV, trichomoniasis, HBV, or HCV was registered. After the initial evaluation, 128 (67.7%) women returned for follow-up, but only 43 (22.8%) repeated screening; among them, 11 (25.6%) were diagnosed with new STIs. Given the high prevalence of STIs in cisgender women, awareness measures to improve screening and prevention strategies in this neglected population are required. Full article
Show Figures

Figure 1

Back to TopTop